Barbara A. Conley - Concepedia

Author

Barbara A. Conley

Also Known As

B A Conley, B CONLEY, B Conley, B. A. Conley, B. Conley, B.A. Conley, Barbara A Conley, Barbara A. Conley, Barbara Conley, Doroshow, James H.

300

Publications

13.5K

Citations

H-Index

137

Concepts

All Affiliations

National Cancer Institute Frederick National Laboratory for Cancer Research Massachusetts General Hospital Dana-Farber Cancer Institute University of Pennsylvania

About

Barbara A. Conley is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	43	2.6K
2	Health Sciences	10	10	413
3	Natural Sciences	3	3	124
4	Education	1	1	10
5	Engineering	1	1	21

Barbara A. Conley

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell, Journal of Clinical Oncology	2007	1K
Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base Rosemary Yancik, Claudette G. Varricchio, Barbara A. Conley Journal of Clinical Oncology AgingCancer Treatment DecisionsCancer RegistrationGeriatric MedicineCancer Education	2001	285
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) Keith T. Flaherty, Robert J. Gray, Alice P. Chen, Journal of Clinical Oncology	2020	281
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF<sup>V600E</sup></i> Mutations: Results of the NCI-MATCH Trial Subprotocol H April K.S. Salama, Shuli Li, Erin Macrae, Journal of Clinical Oncology	2020	277
Criteria for the use of omics-based predictors in clinical trials Lisa M. McShane, Margaret M. Cavenagh, Tracy Lively, Nature	2013	234
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design Keith T. Flaherty, Robert J. Gray, Alice P. Chen, JNCI Journal of the National Cancer Institute	2020	221
Interlaboratory Comparability Study of Cancer Gene Expression Analysis Using Oligonucleotide Microarrays Kevin K. Dobbin, David G. Beer, Matthew Meyerson, Clinical Cancer Research	2005	181
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W Young Kwang Chae, Fangxin Hong, Christos Vaklavas, Journal of Clinical Oncology	2020	175
Nivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) Study Nilofer S. Azad, Robert J. Gray, Michael J. Overman, Journal of Clinical Oncology	2019	163
Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Barbara A. Conley, Merrill J. Egorin, Nancy Tait, PubMed Pharmacological StudySolid TumorsMedicineButyrate ProdrugButyrate Pharmacokinetics	1998	155

Page 1